HSIC - Henry Schein
69.82
| Index: | S&P 500 | P/E: | 28.59 | EPS (ttm): | 2.44 | Insider Own: | 1.35% | Shs Outstand: | 125.15M | Perf Week: | -8.85% |
| Market Cap: | 8.82B | Forward P/E: | 13.47 | EPS next Y: | 5.18 | Insider Trans: | -2.08% | Shs Float: | 123.00M | Perf Month: | -5.30% |
| Income(ttm): | 314.00M | PEG: | 3.39 | EPS next Q: | 1.23 | Inst Own: | 106.58% | Short Float: | 5.25% | Perf Quarter: | -2.53% |
| Revenue(ttm): | 12.50B | P/S: | 0.71 | EPS this Y: | 6.08% | Inst Trans: | 3.53% | Short Ratio: | 3.95 | Perf Half Y: | 3.79% |
| Book/sh: | 27.99 | P/B: | 2.49 | EPS next Y: | 8.55% | ROA: | 3.08% | Short Interest: | 6.45M | Perf Year: | -4.88% |
| Cash/sh: | 1.00 | P/C: | 69.96 | EPS next 5Y: | 8.44% | ROE: | 8.78% | 52W Range: | 63.67 - 82.63 | Perf YTD: | -7.78% |
| Dividend Est.: | - | P/FCF: | 19.12 | EPS past 5Y: | -1.96% | ROI: | 5.54% | 52W High: | -15.50% | Beta: | 0.89 |
| Dividend TTM: | - | Quick Ratio: | 0.82 | Sales past 5Y: | 5.89% | Gross Margin: | 29.62% | 52W Low: | 9.66% | ATR (14): | 2.16 |
| Dividend Ex-Date: | - | Current Ratio: | 1.42 | EPS Y/Y TTM: | -27.46% | Oper. Margin: | 4.79% | RSI (14): | 39.36 | Volatility: | 3.26% 2.76% |
| Employees: | 25000 | Debt/Eq: | 0.85 | Sales Y/Y TTM: | -1.53% | Profit Margin: | 2.51% | Recom: | 2.73 | Target Price: | 74.83 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.62 | EPS Q/Q: | -25.24% | Payout: | 0.00% | Rel Volume: | 1.69 | Prev Close: | 68.95 |
| Sales Surprise: | -1.90% | EPS Surprise: | 4.29% | Sales Q/Q: | 0.38% | Earnings: | Nov 05 BMO | Avg Volume: | 1.63M | Price: | 69.82 |
| SMA20: | -6.50% | SMA50: | -3.36% | SMA200: | -1.41% | Undervalued: 7.18% | Volume: | 2,761,486 | Change: | 1.26% | |
Graham Classic formula value: 55.61
(P/E=8 * 1g) Min value: 36.02
(current P/E * 2g) Max value: 99.63
Average value: 63.75
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.